Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study

被引：0
|
作者：
Patrick J. van der Geest
Nicole G. M. Hunfeld
Sophie E. Ladage
A. B. Johan Groeneveld
机构：
[1] Erasmus University Medical Center,Department of Intensive Care Medicine
[2] Erasmus University Medical Center,Department of Pharmacy
来源：
BMC Infectious Diseases | / 16卷
关键词：
Critically ill; Micafungin; Anidulafungin; Invasive candidiasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins
    Almirante, Benito
    Garnacho-Montero, Jose
    Maseda, Emilio
    Javier Candel, Francisco
    Grau, Santiago
    Guinea, Jesus
    Moreno, Ignacio
    Munoz, Patricia
    Ruiz-Santana, Sergio
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2017, 30 (05) : 355 - 367
  • [32] Invasive fungal infection in critically ill patient: role of micafungin
    Nieto Cabrera, Mercedes
    Escudero Lopez-Cepero, Elena
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2012, 25 (01) : 4 - 9
  • [33] Invasive Candidiasis in Critically Ill Patients: A Prospective Cohort Study in Two Tertiary Care Centers
    Al-Dorzi, Hasan M.
    Sakkijha, Hussam
    Khan, Raymond
    Aldabbagh, Tarek
    Toledo, Aron
    Ntinika, Pendo
    Al Johani, Sameera M.
    Arabi, Yaseen M.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (06) : 542 - 553
  • [34] Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients
    Wang, Bo
    Wang, Yuerong
    Zhang, Luwen
    Lu, Fanbo
    Zhang, Min
    Xu, Yuanhong
    CLINICAL LABORATORY, 2022, 68 (06) : 1257 - 1264
  • [35] Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis
    Perez Civantos, D. V.
    Robles Marcos, M.
    Azanza Perea, J. R.
    Pazos Pacheco, C.
    Garcia-Montoto Perez, F.
    Jerez Gomez-Coronado, V.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 86 : 142 - 146
  • [36] Micafungin versus liposomal amphotericin B (AmBisome®) in paediatric patients with invasive candidiasis or candidaemia
    Arrieta, A.
    Queiroz-Telles, F.
    Berezin, E.
    Freire, A.
    Diekmann, S.
    Koblinger, S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S28 - S28
  • [37] TREATMENT AND PROPHYLAXIS OF INVASIVE CANDIDIASIS WITH ANIDULAFUNGIN, CASPOFUNGIN AND MICAFUNGIN AND ITS IMPACT ON USE AND COSTS - REVIEW OF THE LITERATURE
    Wilke, M. H.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (04) : 180 - 186
  • [38] IDENTIFYING RISK FACTORS FOR INVASIVE CANDIDIASIS IN THE CRITICALLY ILL
    Gamble, Ginger
    Cope, Jessica
    Ashton, Jennifer
    Voils, Stacy
    Ataya, Ali
    Klinker, Kenneth
    Alnuaimat, Hassan
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [39] Invasive candidiasis as a cause of sepsis in the critically ill patient
    Delaloye, Julie
    Calandra, Thierry
    VIRULENCE, 2014, 5 (01) : 161 - 169
  • [40] Low but Sufficient Anidulafungin Exposure in Critically Ill Patients
    van Wanrooy, Marjolijn J. P.
    Rodgers, Michael G. G.
    Uges, Donald R. A.
    Arends, Jan P.
    Zijlstra, Jan G.
    van der Werf, Tjip S.
    Kosterink, Jos G. W.
    Alffenaar, Jan-Willem C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 304 - 308
12345